
|Articles|February 15, 2003
New viscoelastic offers dispersive, cohesive properties
Lexington, KY-One of the newest viscoelastic products approved by the FDA is 1.2% sodium hyaluronate (CoEase, Advanced Medical Optics), which exemplifies the trend toward developing agents with both dispersive and cohesive properties.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025 Takeaways: Cornea, refractive surgery, and aesthetics redefined
2
AAO 2025 Takeaways: The new era of glaucoma treatment and surgical precision
3
AAO 2025 Takeaways: The next frontier in retinal therapeutics arrives
4
Ocular Therapeutix randomizes first patient in HELIOS-3
5

















































.png)


